Filing Details

Accession Number:
0001182489-18-000381
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-05 18:27:33
Reporting Period:
2018-08-31
Accepted Time:
2018-09-05 18:27:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113481 Medicines Co MDCO Pharmaceutical Preparations (2834) 043324394
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204787 Clive Meanwell 8 Sylvan Way
Parsippany NJ 07054
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-31 375 $28.28 352,409 No 4 A Direct
Common Stock Disposition 2018-09-04 50,000 $39.31 302,409 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Shares of common stock acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning March 1, 2018 and ending August 31, 2018. In accordance with the terms of the ESPP, these share were purchased based on 85% of the fair market value closing price of the issuer's common stock on March 1, 2018.
  2. Sales were effected pursuant to a Rule 10b5-1 program adopted by Dr. Meanwell. Dr. Meanwell's 10b5-1 program is terminated.
  3. Represents the weighted average sales price of the shares sold ranging from a low of $39.03 to a high of $39.77 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.